关于：Delta样配体4-Notch阻断与肿瘤放射反应 - Suppr

Suppr

超能文献

Re: Delta-like ligand 4-Notch blockade and tumor radiation response.

作者信息

Masuda Shigeo

出版信息

J Natl Cancer Inst. 2012 Mar 7;104(5):421; author reply 421-2. doi: 10.1093/jnci/djs006. Epub 2012 Jan 20.

DOI:10.1093/jnci/djs006

PMID:22266472

Abstract

摘要

相似文献

Re: Delta-like ligand 4-Notch blockade and tumor radiation response.

J Natl Cancer Inst. 2012 Mar 7;104(5):421; author reply 421-2. doi: 10.1093/jnci/djs006. Epub 2012 Jan 20.

Delta-like ligand 4-notch blockade and tumor radiation response.

J Natl Cancer Inst. 2011 Dec 7;103(23):1778-98. doi: 10.1093/jnci/djr419. Epub 2011 Oct 18.

Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.

Crit Rev Eukaryot Gene Expr. 2016;26(3):239-46. doi: 10.1615/CritRevEukaryotGeneExpr.2016016587.

Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.

Cancer Res. 2015 Oct 1;75(19):4086-96. doi: 10.1158/0008-5472.CAN-14-3773. Epub 2015 Sep 16.

Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):41-52. doi: 10.1007/s10911-006-9011-7.

Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Drug Resist Updat. 2008 Dec;11(6):210-8. doi: 10.1016/j.drup.2008.09.002. Epub 2008 Oct 31.

NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.

Cancer Discov. 2015 Feb;5(2):182-97. doi: 10.1158/2159-8290.CD-14-0650. Epub 2014 Nov 11.

Moving forward one Notch at a time.

J Clin Oncol. 2012 Jul 1;30(19):2291-3. doi: 10.1200/JCO.2012.42.3277. Epub 2012 May 7.

Rational targeting of Notch signaling in cancer.

Oncogene. 2008 Sep 1;27(38):5124-31. doi: 10.1038/onc.2008.226.

Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.

J Med Chem. 2016 Sep 8;59(17):7719-37. doi: 10.1021/acs.jmedchem.5b01516. Epub 2016 Apr 18.

引用本文的文献

Targeting Notch to overcome radiation resistance.

Oncotarget. 2016 Feb 16;7(7):7610-28. doi: 10.18632/oncotarget.6714.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Re: Delta-like ligand 4-Notch blockade and tumor radiation response.

J Natl Cancer Inst. 2012 Mar 7;104(5):421; author reply 421-2. doi: 10.1093/jnci/djs006. Epub 2012 Jan 20.

Delta-like ligand 4-notch blockade and tumor radiation response.

J Natl Cancer Inst. 2011 Dec 7;103(23):1778-98. doi: 10.1093/jnci/djr419. Epub 2011 Oct 18.

Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.

Crit Rev Eukaryot Gene Expr. 2016;26(3):239-46. doi: 10.1615/CritRevEukaryotGeneExpr.2016016587.

Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.

Cancer Res. 2015 Oct 1;75(19):4086-96. doi: 10.1158/0008-5472.CAN-14-3773. Epub 2015 Sep 16.

Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.

J Mammary Gland Biol Neoplasia. 2006 Jan;11(1):41-52. doi: 10.1007/s10911-006-9011-7.

Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Drug Resist Updat. 2008 Dec;11(6):210-8. doi: 10.1016/j.drup.2008.09.002. Epub 2008 Oct 31.

NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.

Cancer Discov. 2015 Feb;5(2):182-97. doi: 10.1158/2159-8290.CD-14-0650. Epub 2014 Nov 11.

Moving forward one Notch at a time.

J Clin Oncol. 2012 Jul 1;30(19):2291-3. doi: 10.1200/JCO.2012.42.3277. Epub 2012 May 7.

Rational targeting of Notch signaling in cancer.

Oncogene. 2008 Sep 1;27(38):5124-31. doi: 10.1038/onc.2008.226.

Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.

J Med Chem. 2016 Sep 8;59(17):7719-37. doi: 10.1021/acs.jmedchem.5b01516. Epub 2016 Apr 18.

引用本文的文献

Targeting Notch to overcome radiation resistance.

Oncotarget. 2016 Feb 16;7(7):7610-28. doi: 10.18632/oncotarget.6714.